Hosted by Margo Tank, Partner at Buckley Sandler, LLP and Bob Flinton, Vice President of Marketing and Product Management at Surety, this webinar will address the process of protecting electronic intellectual property (IP) in the biopharmaceutical and life sciences world. As these markets engage in and deploy digital processes, the use of electronic or digital signatures as methods for protecting research IP is becoming widespread. The benefits are obvious – convenience and efficiency. However, along with these benefits also come risks, including the risk of tampering, fraud and inadmissibility in court. But most R&D-centric organizations often overlook the fact that by just “signing” their electronic research records, they haven’t fully implemented the protections they need to prove ownership, authenticity and “time-of-creation” (first to invent). Organizations need to go a step further than just “signing” their valuable IP, but they should also “seal” it to prove the content was created at a specific point in time and hasn’t been altered since. This virtual event will explore these “sign and seal” concepts and requirements, and will discuss how you can implement simple, cost-effective controls to achieve legally enforceable scientific IP for the life of the content.
What: Pharmaceutical Technology webinar, “Protect and Legally Defend Your Scientific Intellectual Property: Digital Signatures Alone Aren’t Enough”
Speakers: Margo Tank, Partner at Buckley Sandler, LLP and Bob Flinton, Vice President of Marketing and Product Management at Surety
When: March 31, 2011 at 2:00 p.m. EDT
Registration: Register online for free